Prognostic factors in surgically treated stage IB-IIB carcinoma of the cervix with negative lymph nodes

International Journal of Gynecological Cancer

Volumn 8, Issue 1, 1998, Pages 23-26

  Comerci, G ^a   Bolger, B S ^a   Flannelly, G ^a   Maini, M ^a   De Barros Lopes, A ^a   Monaghan, J M ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Cervix neoplasm; Negative lymph nodes; Prognostic factors; Surgery

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0031887451     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1998.09754.x     Document Type: Article

References (15)

1. Larson DM, Stringer CA, Copeland LJ, Gershenson DM, Malone JM Jr, Rutledge FN. Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: Role of adjuvant radiotherapy. Obstet Gynecol 1987; 69: 378-81.
2. Rettenmaier MA, Casanova DM, Micha JP, et al. Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage IB cervical cancer. Cancer 1989; 63: 2220-3.
3. Remy JC, Maio TD, Fruchter RG, et al. Adjunctive radiation after radical hysterectomy in stage IB squamous cell carcinoma of the cervix. Gynecol Oncol 1990; 38: 161-5.
4. Alvarez RD, Potter ME, Soong S-J, et al. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. Gynecol Oncol 1991; 43: 108-12.
5. Burghardt E, Pickel H. Local spread and lymph node involvement in cervical cancer. Obstet Gynecol 1978; 52: 138-45.
6. Inoue T, Okumura M. Prognostic significance of parametrial extension in patients with cervical carcinoma stage IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation. Cancer 1984; 54: 1714-9.
7. Delgado G, Bundy BN, Fowler WC Jr, et al. A prospective surgical pathological study of stage 1 squamous carcinoma of the cervix: A gynecologic oncology group study. Gynecol Oncol 1989; 35: 314-20.
8. Simon ML, Gore H, Shingleton HM, Soong S-J, Orr JW Jr, Hatch KD. A study of superficially invasive carcinoma of the cervix. Obstet Gynecol 1986; 68: 19-24.
9. White CD, Morley GW, Kumar NB. The prognostic significance of tumor emboli in lymphatic or vascular spaces of the cervical stroma in stage IB squamous cell carcinoma of the cervix. Am J Obstet Gynecol 1984; 149: 342-9.
10. Crissman JD, Makuch R, Budhraja M. Histopalogic grading of squamous cell carcinoma of the uterine cervix: An evaluation of 70 stage IB patients. Cancer 1985; 55: 1590-6.
11. Ng HT, Shyu SK, Chen YK, Yuan CC, Chao KF, Kan FF. A scoring system for predicting recurrence of cervical cancer. Int J Gynecol Cancer 1992; 2: 75-8.
12. Crissman JD, Budhraja M, Aron BS, Cummings G. Histopatologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix: An evaluation of 91 patients treated primarily with radiation therapy. Int J Gynecol Pathol 1987; 6: 97-103.
13. Sorensen FB, Bichel P, Jakosen A. DNA level and stereologic estimates of nuclear volume in squamous cell carcinomas of the uterine cervix. A comparative study with analysis of prognostic impact. Cancer 1992; 69: 187-99.
14. Stockler M, Russel P, Mcgahan S, Elliott PM, Dalrymple C, Tattersall M. Prognosis and prognostic factors in node-negative cervix cancer. Int J Gynecol Cancer 1996; 6: 477-82.
15. Baltzer J, Koepcke W. Tumor size and lymph node metastases in squamous cell carcinoma of the uterine cervix. Arch Gynecol 1979; 227: 271-8.